Neutrophil diversity and plasticity in tumour progression and therapy

S Jaillon, A Ponzetta, D Di Mitri, A Santoni… - Nature Reviews …, 2020 - nature.com
Neutrophils play a key role in defence against infection and in the activation and regulation
of innate and adaptive immunity. In cancer, tumour-associated neutrophils (TANs) have …

Activated fibroblasts in cancer: Perspectives and challenges

G Caligiuri, DA Tuveson - Cancer cell, 2023 - cell.com
Activated fibroblasts in tumors, or cancer-associated fibroblasts (CAFs), have become a
popular research area over the past decade. As important players in many aspects of tumor …

Neutrophil plasticity in the tumor microenvironment

MA Giese, LE Hind… - Blood, The Journal of the …, 2019 - ashpublications.org
Neutrophils act as the body's first line of defense against infection and respond to diverse
inflammatory cues, including cancer. Neutrophils display plasticity, with the ability to adapt …

[HTML][HTML] Neutrophil-activating therapy for the treatment of cancer

IL Linde, TR Prestwood, J Qiu, G Pilarowski, MH Linde… - Cancer Cell, 2023 - cell.com
Despite their cytotoxic capacity, neutrophils are often co-opted by cancers to promote
immunosuppression, tumor growth, and metastasis. Consequently, these cells have …

Exploiting innate immunity for cancer immunotherapy

M Yi, T Li, M Niu, Q Mei, B Zhao, Q Chu, Z Dai, K Wu - Molecular cancer, 2023 - Springer
Immunotherapies have revolutionized the treatment paradigms of various types of cancers.
However, most of these immunomodulatory strategies focus on harnessing adaptive …

Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy

AE Vilgelm, A Richmond - Frontiers in immunology, 2019 - frontiersin.org
Chemokines are small secreted proteins that orchestrate migration and positioning of
immune cells within the tissues. Chemokines are essential for the function of the immune …

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent …

AH Lee, L Sun, AY Mochizuki, JG Reynoso… - Nature …, 2021 - nature.com
Primary brain tumors, such as glioblastoma (GBM), are remarkably resistant to
immunotherapy, even though pre-clinical models suggest effectiveness. To understand this …

Tumor-associated myeloid cells: diversity and therapeutic targeting

A Mantovani, F Marchesi, S Jaillon… - Cellular & molecular …, 2021 - nature.com
Myeloid cells in tumor tissues constitute a dynamic immune population characterized by a
non-uniform phenotype and diverse functional activities. Both tumor-associated …

[HTML][HTML] Targeting immune cells for cancer therapy

SY Gun, SWL Lee, JL Sieow, SC Wong - Redox biology, 2019 - Elsevier
Recent years have seen a renaissance in the research linking inflammation and cancer with
immune cells playing a central role in smouldering inflammation in the tumor …

Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments

W Wang, H Zheng, J Jiang, Z Li, D Jiang, X Shi… - Nature …, 2022 - nature.com
While hypoxia promotes carcinogenesis, tumour aggressiveness, metastasis, and resistance
to oncological treatments, the impacts of hyperoxia on tumours are rarely explored because …